Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

908
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
908

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Pakistan: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.

The Journal of antimicrobial chemotherapy·2025
Same author

Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Ukraine: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.

The Journal of antimicrobial chemotherapy·2025
Same author

Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Türkiye: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.

The Journal of antimicrobial chemotherapy·2025
Same author

Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Kuwait and the United Arab Emirates: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.

The Journal of antimicrobial chemotherapy·2025
Same author

Antimicrobial resistance among agents of hospital-acquired lower respiratory tract infection in the UK and Ireland: trends from 2008/2009 to 2018/2019.

The Journal of antimicrobial chemotherapy·2025
Same author

Activity of mecillinam against USA urinary tract clinical isolates from 2017 to 2020 including isolates resistant to comparator antibiotics.

Journal of global antimicrobial resistance·2024
Same journal

Favipiravir tissue distribution and inhibitory quotients in preclinical models: towards a pipeline for evidence-based antiviral repurposing.

The Journal of antimicrobial chemotherapy·2026
Same journal

A review of the randomized clinical trial results from the Staphylococcus aureus network adaptive platform (SNAP) meticillin-susceptible (MSSA) and penicillin-susceptible (PSSA) domains and CloCeBa.

The Journal of antimicrobial chemotherapy·2026
Same journal

Incidence and factors associated with subtherapeutic cefazolin levels among patients with severe infections.

The Journal of antimicrobial chemotherapy·2026
Same journal

Emerging resistance in staphylococci following long-term dalbavancin treatment for prosthetic joint infections.

The Journal of antimicrobial chemotherapy·2026
Same journal

Microbiology testing around the time of antibiotic initiation among residents of long-term care facilities.

The Journal of antimicrobial chemotherapy·2026
Same journal

Insights into the mechanisms underlying cell wall-active agents and gentamicin bactericidal synergism against Enterococcus faecalis.

The Journal of antimicrobial chemotherapy·2026
See all related articles

Related Experiment Video

Updated: Jan 17, 2026

Rapid Antimicrobial Susceptibility Testing by Stimulated Raman Scattering Imaging of Deuterium Incorporation in a Single Bacterium
12:08

Rapid Antimicrobial Susceptibility Testing by Stimulated Raman Scattering Imaging of Deuterium Incorporation in a Single Bacterium

Published on: February 14, 2022

3.3K

Modification of antimicrobial susceptibility testing methods.

Ian Morrissey1, Jean B Patel2

  • 1Antimicrobial Focus Ltd., T15 Allen House, The Maltings, Sawbridgeworth, Herts CM21 9JX, UK.

The Journal of Antimicrobial Chemotherapy
|September 19, 2025
PubMed
Summary
This summary is machine-generated.

Developing new antimicrobial agents requires reliable antimicrobial susceptibility testing (AST). Early, scientifically justified use of standard broth microdilution (BMD) methods ensures accurate results and timely patient access to novel drugs.

More Related Videos

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

27.6K
Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
08:54

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds

Published on: February 14, 2018

20.0K

Related Experiment Videos

Last Updated: Jan 17, 2026

Rapid Antimicrobial Susceptibility Testing by Stimulated Raman Scattering Imaging of Deuterium Incorporation in a Single Bacterium
12:08

Rapid Antimicrobial Susceptibility Testing by Stimulated Raman Scattering Imaging of Deuterium Incorporation in a Single Bacterium

Published on: February 14, 2022

3.3K
Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

27.6K
Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
08:54

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds

Published on: February 14, 2018

20.0K

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Antimicrobial resistance (AMR) necessitates the development of new antimicrobial agents.
  • Reliable antimicrobial susceptibility testing (AST) is crucial for guiding treatment decisions and ensuring patient access to effective therapies.
  • Standardized AST methods are essential for the early and accurate evaluation of novel antimicrobial agents.

Purpose of the Study:

  • To emphasize the importance of establishing reliable antimicrobial susceptibility testing (AST) methods early in the development of new antimicrobial agents.
  • To highlight the standard reference method for AST: broth microdilution (BMD) in cation-adjusted Mueller-Hinton broth (CAMHB).
  • To caution against scientifically unjustified modifications to reference AST methods.

Main Methods:

  • Adherence to established reference methods, such as Clinical and Laboratory Standards Institute (CLSI) M07 and International Organization for Standardization (ISO) 20776-1 for broth microdilution (BMD).
  • Scientific justification for any necessary modifications to standard AST protocols.
  • Rigorous evaluation of antimicrobial agents using reference methods prior to finalization of joint CLSI and European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidance.

Main Results:

  • The standard broth microdilution (BMD) method in cation-adjusted Mueller-Hinton broth (CAMHB) is the reference for AST.
  • Modifications to BMD methods must be scientifically valid and clinically relevant.
  • Unjustified modifications can lead to inaccurate minimal inhibitory concentration (MIC) values and hinder drug development.

Conclusions:

  • Early and thoughtful establishment of reliable AST methods is critical for the successful development and clinical adoption of new antimicrobial agents.
  • Deviations from reference AST methods should be scientifically justified to avoid misleading results and regulatory challenges.
  • Continued adherence to standardized reference methods, like BMD, ensures the integrity of AST data and facilitates timely patient access to effective treatments.